{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:36:42Z","timestamp":1778884602497,"version":"3.51.4"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T00:00:00Z","timestamp":1434067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0129859","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T18:33:44Z","timestamp":1434134024000},"page":"e0129859","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Mitogen-Inducible Gene-6 Mediates Feedback Inhibition from Mutated BRAF towards the Epidermal Growth Factor Receptor and Thereby Limits Malignant Transformation"],"prefix":"10.1371","volume":"10","author":[{"given":"Malgorzata","family":"Milewska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"Guerriero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Birtwistle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Quehenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Hatzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris N.","family":"Kholodenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oreste","family":"Segatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Kolch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Zebisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,6,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nrm1498","article-title":"The RAF proteins take centre stage","volume":"5","author":"C Wellbrock","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"H Davies","year":"2002","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1007\/s00018-006-6005-y","article-title":"Back to the roots: the remarkable RAF oncogene story","volume":"63","author":"A Zebisch","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrd3847","article-title":"Vemurafenib: the first drug approved for BRAF-mutant cancer","volume":"11","author":"G Bollag","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1756-8722-6-30","article-title":"B-Raf and the inhibitors: from bench to bedside","volume":"6","author":"T Huang","year":"2013","journal-title":"J Hematol Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature10868","article-title":"Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR","volume":"483","author":"A Prahallad","year":"2012","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.surg.2013.06.024","article-title":"Clinical and therapeutic implications of Sprouty2 feedback dysregulation in BRAF V600E-mutation-positive papillary thyroid cancer","volume":"154","author":"LA Dultz","year":"2013","journal-title":"Surgery"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature13121","article-title":"Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma","volume":"508","author":"C Sun","year":"2014","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1038\/sj.onc.1205823","article-title":"Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control","volume":"21","author":"M Fiorini","year":"2002","journal-title":"Oncogene"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bbaexp.2004.07.002","article-title":"Regulation of Gene33 expression by insulin requires MEK-ERK activation","volume":"1679","author":"AB Keeton","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1038\/sj.onc.1210590","article-title":"The evolutionarily conserved EBR module of RALT\/MIG6 mediates suppression of the EGFR catalytic activity","volume":"26","author":"S Anastasi","year":"2007","journal-title":"Oncogene"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nature05998","article-title":"Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface","volume":"450","author":"X Zhang","year":"2007","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1038\/sj.onc.1206516","article-title":"Feedback inhibition by RALT controls signal output by the ErbB network","volume":"22","author":"S Anastasi","year":"2003","journal-title":"Oncogene"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.onc.1209790","article-title":"Evidence that MIG-6 is a tumor-suppressor gene","volume":"26","author":"YW Zhang","year":"2007","journal-title":"Oncogene"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/mc.20815","article-title":"Downregulation of Mig-6 in nonsmall-cell lung cancer is associated with EGFR signaling","volume":"51","author":"Z Li","year":"2012","journal-title":"Mol Carcinog"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/hep.23428","article-title":"Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma","volume":"51","author":"M Reschke","year":"2010","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"E554","DOI":"10.1210\/jc.2010-1800","article-title":"Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer","volume":"96","author":"CI Lin","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1038\/sj.onc.1208658","article-title":"Loss of RALT\/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin","volume":"24","author":"S Anastasi","year":"2005","journal-title":"Oncogene"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1073\/pnas.0914930107","article-title":"Mig-6 controls EGFR trafficking and suppresses gliomagenesis","volume":"107","author":"H Ying","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nm1401","article-title":"Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation","volume":"12","author":"I Ferby","year":"2006","journal-title":"Nat Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1038\/onc.2010.126","article-title":"The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression","volume":"29","author":"TH Kim","year":"2010","journal-title":"Oncogene"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1242\/dev.032979","article-title":"Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasis","volume":"136","author":"N Jin","year":"2009","journal-title":"Development"},{"key":"ref23","article-title":"Loss of Mig6 accelerates initiation and progression of mutant Epidermal growth factor receptor-driven lung adenocarcinoma","author":"TK Maity","year":"2015","journal-title":"Cancer Discov"},{"key":"ref24","article-title":"ErbB2 Pathway Activation upon Smad4 Loss Promotes Lung Tumor Growth and Metastasis","author":"J Liu","year":"2015","journal-title":"Cell Rep"},{"key":"ref25","article-title":"Future Aspects of Tumor Suppressor Gene","author":"YW Zhang","year":"2013"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.surg.2008.07.028","article-title":"Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF(V600E) positive papillary thyroid cancers","volume":"144","author":"DT Ruan","year":"2008","journal-title":"Surgery"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/2159-8290.CD-12-0386","article-title":"Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma","volume":"3","author":"MR Girotti","year":"2013","journal-title":"Cancer Discov"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1083\/jcb.201002032","article-title":"A two-tiered mechanism of EGFR inhibition by RALT\/MIG6 via kinase suppression and receptor degradation","volume":"189","author":"Y Frosi","year":"2010","journal-title":"J Cell Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1038\/leu.2012.61","article-title":"Frequent loss of RAF kinase inhibitor protein expression in acute myeloid leukemia","volume":"26","author":"A Zebisch","year":"2012","journal-title":"Leukemia"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/leu.2009.68","article-title":"Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations","volume":"23","author":"A Zebisch","year":"2009","journal-title":"Leukemia"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/sj.leu.2403713","article-title":"Bedside RNA stabilizing kit systems for gene expression analysis of acute leukemias: influence of non-neoplastic white blood cells","volume":"19","author":"A Zebisch","year":"1005","journal-title":"Leukemia"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1748-717X-7-70","article-title":"Identification of stable endogenous control genes for transcriptional profiling of photon, proton and carbon-ion irradiated cells","volume":"7","author":"GD Sharungbam","year":"2012","journal-title":"Radiat Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"D1144","DOI":"10.1093\/nar\/gkr1013","article-title":"PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update","volume":"40","author":"X Wang","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 5","key":"ref34","doi-asserted-by":"crossref","first-page":"v214","DOI":"10.1093\/annonc\/mdq190","article-title":"Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"F Pacini","year":"2010","journal-title":"Ann Oncol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"E Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"ref36","first-page":"pl1","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"J Gao","year":"2013","journal-title":"Sci Signal"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.molcel.2012.12.018","article-title":"Effects of Raf dimerization and its inhibition on normal and disease-associated Raf signaling","volume":"49","author":"AK Freeman","year":"2013","journal-title":"Mol Cell"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1128\/MCB.00569-09","article-title":"Impact of feedback phosphorylation and Raf heterodimerization on normal and mutant B-Raf signaling","volume":"30","author":"DA Ritt","year":"2010","journal-title":"Mol Cell Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1124\/jpet.104.069138","article-title":"Inhibition of epidermal growth factor receptor activity by two pyrimidopyrimidine derivatives","volume":"311","author":"FF Solca","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","article-title":"Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF","volume":"116","author":"PT Wan","year":"2004","journal-title":"Cell"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/ng1749","article-title":"Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome","volume":"38","author":"T Niihori","year":"2006","journal-title":"Nat Genet"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1126\/science.1124642","article-title":"Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome","volume":"311","author":"P Rodriguez-Viciana","year":"2006","journal-title":"Science"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"7371","DOI":"10.1158\/0008-5472.CAN-14-0794","article-title":"Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation","volume":"74","author":"TH Kim","year":"2014","journal-title":"Cancer Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1083\/jcb.120.1.85","article-title":"Consumption of EGF by A431 cells: evidence for receptor recycling","volume":"120","author":"H Masui","year":"1993","journal-title":"J Cell Biol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ng1987","article-title":"A module of negative feedback regulators defines growth factor signaling","volume":"39","author":"I Amit","year":"2007","journal-title":"Nat Genet"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.molcel.2009.04.034","article-title":"The juxtamembrane region of the EGF receptor functions as an activation domain","volume":"34","author":"M Red Brewer","year":"2009","journal-title":"Mol Cell"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1158\/2159-8290.CD-13-0440","article-title":"Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis","volume":"4","author":"TJ Parmenter","year":"2014","journal-title":"Cancer Discov"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.surg.2011.09.014","article-title":"Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-kappaB activity","volume":"150","author":"CI Lin","year":"2011","journal-title":"Surgery"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1210\/jc.2012-2104","article-title":"BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis","volume":"97","author":"C Li","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/emboj.2012.88","article-title":"Chk1 phosphorylates the tumour suppressor Mig-6, regulating the activation of EGF signalling","volume":"31","author":"N Liu","year":"2012","journal-title":"EMBO J"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1158\/2159-8290.CD-12-0531","article-title":"Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF-mutant thyroid carcinomas","volume":"3","author":"C Montero-Conde","year":"2013","journal-title":"Cancer Discov"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/cncr.26500","article-title":"The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis","volume":"118","author":"TH Kim","year":"2012","journal-title":"Cancer"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.molcel.2011.10.016","article-title":"Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras","volume":"44","author":"D Matallanas","year":"2011","journal-title":"Mol Cell"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ccr.2012.08.001","article-title":"EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma","volume":"22","author":"C Navas","year":"2012","journal-title":"Cancer Cell"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(00)00026-X","article-title":"The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development","volume":"102","author":"M Sibilia","year":"2000","journal-title":"Cell"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.mce.2010.04.008","article-title":"EGF receptor activation by GPCRs: an universal pathway reveals different versions","volume":"331","author":"C Liebmann","year":"2011","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"ref57","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.cellsig.2007.06.023","article-title":"Mechanisms for oncogenic activation of the epidermal growth factor receptor","volume":"19","author":"R Zandi","year":"2007","journal-title":"Cell Signal"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1158\/1078-0432.CCR-11-1155","article-title":"Role of BRAF in thyroid oncogenesis","volume":"17","author":"LM Caronia","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1158\/1078-0432.CCR-11-0933","article-title":"Synergistic action of a RAF inhibitor and a dual PI3K\/mTOR inhibitor in thyroid cancer","volume":"17","author":"N Jin","year":"2011","journal-title":"Clin Cancer Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0129859","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T08:07:56Z","timestamp":1540022876000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0129859"}},"subtitle":[],"editor":[{"given":"Marie-Jos\u00e9e","family":"Boucher","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,12]]},"references-count":59,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0129859","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,12]]}}}